Logo image of BSFC

BLUE STAR FOODS CORP (BSFC) Stock Fundamental Analysis

USA - NASDAQ:BSFC - US09606H3093 - Common Stock

0.1476 USD
-0.14 (-48.21%)
Last: 12/19/2024, 8:20:42 PM
0.1301 USD
-0.02 (-11.86%)
After Hours: 12/19/2024, 8:20:42 PM
Fundamental Rating

2

Overall BSFC gets a fundamental rating of 2 out of 10. We evaluated BSFC against 89 industry peers in the Food Products industry. BSFC may be in some trouble as it scores bad on both profitability and health. BSFC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BSFC had negative earnings in the past year.
BSFC had a negative operating cash flow in the past year.
BSFC had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BSFC reported negative operating cash flow in multiple years.
BSFC Yearly Net Income VS EBIT VS OCF VS FCFBSFC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -62.30%, BSFC is doing worse than 89.01% of the companies in the same industry.
BSFC's Return On Equity of -103.34% is on the low side compared to the rest of the industry. BSFC is outperformed by 82.42% of its industry peers.
Industry RankSector Rank
ROA -62.3%
ROE -103.34%
ROIC N/A
ROA(3y)-79.62%
ROA(5y)-65.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BSFC Yearly ROA, ROE, ROICBSFC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5K 10K 15K 20K

1.3 Margins

Looking at the Gross Margin, with a value of 4.71%, BSFC is doing worse than 87.91% of the companies in the same industry.
In the last couple of years the Gross Margin of BSFC has declined.
The Profit Margin and Operating Margin are not available for BSFC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.46%
GM growth 5Y-30%
BSFC Yearly Profit, Operating, Gross MarginsBSFC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

More info and screens

3

2. Health

2.1 Basic Checks

BSFC does not have a ROIC to compare to the WACC, probably because it is not profitable.
BSFC has more shares outstanding than it did 1 year ago.
BSFC has more shares outstanding than it did 5 years ago.
BSFC has a better debt/assets ratio than last year.
BSFC Yearly Shares OutstandingBSFC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100K 200K 300K 400K
BSFC Yearly Total Debt VS Total AssetsBSFC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

BSFC has an Altman-Z score of -7.08. This is a bad value and indicates that BSFC is not financially healthy and even has some risk of bankruptcy.
BSFC's Altman-Z score of -7.08 is on the low side compared to the rest of the industry. BSFC is outperformed by 90.11% of its industry peers.
BSFC has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
BSFC has a better Debt to Equity ratio (0.21) than 63.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -7.08
ROIC/WACCN/A
WACC17.78%
BSFC Yearly LT Debt VS Equity VS FCFBSFC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

BSFC has a Current Ratio of 1.86. This is a normal value and indicates that BSFC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.86, BSFC is in line with its industry, outperforming 57.14% of the companies in the same industry.
BSFC has a Quick Ratio of 1.06. This is a normal value and indicates that BSFC is financially healthy and should not expect problems in meeting its short term obligations.
BSFC's Quick ratio of 1.06 is fine compared to the rest of the industry. BSFC outperforms 65.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.06
BSFC Yearly Current Assets VS Current LiabilitesBSFC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

BSFC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.23%, which is quite impressive.
Looking at the last year, BSFC shows a very negative growth in Revenue. The Revenue has decreased by -17.30% in the last year.
Measured over the past years, BSFC shows a very negative growth in Revenue. The Revenue has been decreasing by -28.23% on average per year.
EPS 1Y (TTM)98.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.57%
Revenue 1Y (TTM)-17.3%
Revenue growth 3Y-24.28%
Revenue growth 5Y-28.23%
Sales Q2Q%-43.38%

3.2 Future

BSFC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.79% yearly.
The Revenue is expected to grow by 42.29% on average over the next years. This is a very strong growth
EPS Next Y112.5%
EPS Next 2Y32.29%
EPS Next 3Y20.51%
EPS Next 5Y12.79%
Revenue Next Year202.73%
Revenue Next 2Y42.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BSFC Yearly Revenue VS EstimatesBSFC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
BSFC Yearly EPS VS EstimatesBSFC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -100 -200

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BSFC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BSFC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BSFC Price Earnings VS Forward Price EarningsBSFC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSFC Per share dataBSFC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

BSFC's earnings are expected to grow with 20.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.29%
EPS Next 3Y20.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BSFC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE STAR FOODS CORP

NASDAQ:BSFC (12/19/2024, 8:20:42 PM)

After market: 0.1301 -0.02 (-11.86%)

0.1476

-0.14 (-48.21%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-18 2024-11-18/amc
Earnings (Next)N/A N/A
Inst Owners0.32%
Inst Owner Change-66.86%
Ins Owners1.69%
Ins Owner Change0%
Market Cap1.17M
Analysts82.86
Price TargetN/A
Short Float %0.6%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-59.92%
Min Revenue beat(2)-67.04%
Max Revenue beat(2)-52.8%
Revenue beat(4)0
Avg Revenue beat(4)-64.39%
Min Revenue beat(4)-71.33%
Max Revenue beat(4)-52.8%
Revenue beat(8)0
Avg Revenue beat(8)-60.22%
Revenue beat(12)1
Avg Revenue beat(12)-53.56%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.25
EV/EBITDA N/A
EPS(TTM)-6.5
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.75
BVpS0.6
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.3%
ROE -103.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.71%
FCFM N/A
ROA(3y)-79.62%
ROA(5y)-65.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.46%
GM growth 5Y-30%
F-Score4
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -496.72%
Cap/Sales 2.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.06
Altman-Z -7.08
F-Score4
WACC17.78%
ROIC/WACCN/A
Cap/Depr(3y)1200.31%
Cap/Depr(5y)728.58%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.57%
EPS Next Y112.5%
EPS Next 2Y32.29%
EPS Next 3Y20.51%
EPS Next 5Y12.79%
Revenue 1Y (TTM)-17.3%
Revenue growth 3Y-24.28%
Revenue growth 5Y-28.23%
Sales Q2Q%-43.38%
Revenue Next Year202.73%
Revenue Next 2Y42.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year285.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.64%
OCF growth 3YN/A
OCF growth 5YN/A